Found 5 results

Name Type of Offering Accepted Date
Keros Therapeutics, Inc. See All Filings
D 2018-11-21 08:16:36
Amount To Be Raised $22,999,928
Associated Brokers / Dealers N/A
CIK Number 0001664710
Filed Document 0001664710-18-000001
Exclusions or Exemptions 506b
Accepted Date 2018-11-21 08:16:36
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business MASSACHUSETTS
Revenue or Assets Decline to Disclose
Type of Security Equity
Keros Therapeutics, Inc. See All Filings
D 2016-04-28
Amount To Be Raised $10,000,078
Associated Brokers / Dealers N/A
CIK Number 0001664710
Filed Document 0001664710-16-000001
Exclusions or Exemptions 506b
Accepted Date 2016-04-28
Type of Offering D
Industry Biotechnology
Offering Tier N/A
Principal Place of Business MASSACHUSETTS
Revenue or Assets Decline to Disclose
Type of Security Equity
Keros Therapeutics, Inc. See All Filings
D/A 2017-11-13 13:54:49
Amount To Be Raised $11,000,000
Associated Brokers / Dealers N/A
CIK Number 0001664710
Filed Document 0001664710-17-000002
Exclusions or Exemptions 506b
Accepted Date 2017-11-13 13:54:49
Type of Offering D/A
Industry Biotechnology
Offering Tier N/A
Principal Place of Business MASSACHUSETTS
Revenue or Assets Decline to Disclose
Type of Security Equity
Keros Therapeutics, Inc. See All Filings
D/A 2016-08-18 16:37:12
Amount To Be Raised $11,000,078
Associated Brokers / Dealers N/A
CIK Number 0001664710
Filed Document 0001664710-16-000002
Exclusions or Exemptions 506b
Accepted Date 2016-08-18 16:37:12
Type of Offering D/A
Industry Biotechnology
Offering Tier N/A
Principal Place of Business MASSACHUSETTS
Revenue or Assets Decline to Disclose
Type of Security Equity
Keros Therapeutics, Inc. See All Filings
D 2020-03-12 15:15:24
Amount To Be Raised $56,000,057
Associated Brokers / Dealers N/A
CIK Number 0001664710
Filed Document 0001664710-20-000001
Exclusions or Exemptions 506b
Accepted Date 2020-03-12 15:15:24
Type of Offering D
Industry Other
Offering Tier N/A
Principal Place of Business MASSACHUSETTS
Revenue or Assets Decline to Disclose
Type of Security Equity